Cyberonics invests in sleep apnea treatment – Yahoo! Finance

An implant designed to treat obstructive sleep apnea is expected to begin clinical trials in the US soon. Im Thera’s neurostimulation device uses an electrode to control certain muscles of the tongue thus clearing air passageways. It’s an experimental device and the company is trying to get approval from the European Union.

HOUSTON (AP) — Cyberonics Inc., a maker of implantable neurological devices, said Wednesday it made a $4 million investment in ImThera Medical, a San….

One of the causes of sleep apnea is the collapse of the soft tissue at the back of the throat thus obstructing the passage of air to the lungs. This stoppage of breathing could last a few seconds or until the brain wakes you up alerting you of lack of oxygen intake.

Click here to visit the original source of this post

This entry was posted in Obstructive Sleep Apnea, Sleep Apnea Medical News, Sleep Apnea News, Sleep Apnea Symptoms. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *